TNF Pharmaceuticals, Inc.
TNFA
$0.146
$0.0096.57%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -14.68M | -23.36M | -23.66M | -17.69M | -12.29M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.55M | 15.30M | 12.87M | 5.16M | -1.26M |
| Change in Net Operating Assets | -1.57M | -761.80K | 800.80K | 3.01M | 2.78M |
| Cash from Operations | -9.70M | -8.82M | -9.99M | -9.51M | -10.77M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4.29M | -6.10M | -1.27M | -993.90K | 13.85M |
| Cash from Investing | -4.29M | -6.10M | -1.27M | -993.90K | 13.85M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 14.00M | 14.00M | 14.00M | 14.00M | 0.00 |
| Repurchase of Preferred Stock | 0.00 | -73.50K | -163.10K | -163.10K | -163.10K |
| Total Dividends Paid | -1.36M | -2.65M | -2.74M | -2.74M | -2.74M |
| Other Financing Activities | 68.10K | 0.00 | -77.10K | -145.20K | -145.20K |
| Cash from Financing | 13.85M | 12.42M | 12.15M | 10.95M | -3.05M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -152.40K | -2.51M | 894.00K | 442.20K | 37.10K |